For research use only. Not for therapeutic Use.
MPEP hydrochloride (Cat No.:I002681) is a selective antagonist of the metabotropic glutamate receptor 5 (mGluR5), a receptor involved in neurotransmission and linked to various neurological disorders. MPEP is commonly used in preclinical research to study the role of mGluR5 in conditions such as Parkinson’s disease, schizophrenia, anxiety, and drug addiction. By inhibiting mGluR5, MPEP can modulate glutamate signaling in the brain, which may help alleviate symptoms associated with these disorders. It is primarily used in research settings to explore potential therapeutic approaches targeting glutamatergic dysfunction.
Catalog Number | I002681 |
CAS Number | 219911-35-0 |
Synonyms | 2-methyl-6-(2-phenylethynyl)pyridine;hydrochloride |
Molecular Formula | C14H12ClN |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | DMSO ≥30 mg/mL; Water <1 mg/mL |
Storage | Store at -20°C |
IC50 | 36 nM |
IUPAC Name | 2-methyl-6-(2-phenylethynyl)pyridine;hydrochloride |
InChI | InChI=1S/C14H11N.ClH/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13;/h2-9H,1H3;1H |
InChIKey | PKDHDJBNEKXCBI-UHFFFAOYSA-N |
SMILES | CC1=NC(=CC=C1)C#CC2=CC=CC=C2.Cl |
Reference | <p style=/line-height:25px/> |